Today: 20 May 2026
Visa stock slips as SEC filing presses independent chair vote ahead of annual meeting
8 January 2026
1 min read

Visa stock slips as SEC filing presses independent chair vote ahead of annual meeting

NEW YORK, Jan 8, 2026, 13:33 EST — Regular session

  • Visa shares down about 1% in afternoon trade as governance filing hits the tape
  • Shareholder group urges support for Proposal 5 to lock in an independent board chair policy
  • Markets look to Friday’s U.S. jobs report after jobless claims ticked higher

Visa Inc shares slid nearly 1% on Thursday, underperforming some payments peers, as investors weighed a fresh SEC filing urging a vote to hardwire an independent board chair policy. The stock was down $3.45 at $352.43, after dipping as low as $349.83 in the session.

The governance push lands late in proxy season, with Visa set to hold its annual meeting on Jan. 27 in an online-only format. That vote can pull in big index and pension holders who tend to take a harder look at board structure once ballots go live.

In a notice of exempt solicitation filed with the U.S. Securities and Exchange Commission, the National Legal and Policy Center urged shareholders to vote for Proposal 5, which would require the chair and CEO roles to remain split and, “whenever possible,” have an independent director as chair. The filing noted Visa’s CEO is Ryan McInerney and the current board chair is John F. Lundgren, with the roles already separate today; the proposal would make that separation a standing policy. SEC

The stock move also played out against a jittery rates backdrop, with Treasury yields rising and investors bracing for Friday’s jobs report. “It’s not clear how Fed policy should or will react,” said Guy LeBas, chief fixed income strategist at Janney Montgomery Scott, as traders weighed the path for rate cuts this year. Reuters

Thursday’s data did little to settle that debate: initial jobless claims rose 8,000 to 208,000 in the week ended Jan. 3, while continuing claims climbed to 1.914 million. “Firms are successfully doing more with less labor,” said Matthew Martin, senior U.S. economist at Oxford Economics, as the Labor Department reported a sharp pick-up in productivity. Reuters

For Visa, the macro read-through is straightforward: weaker hiring can bleed into softer consumer spend, and that tends to show up in card volumes with a lag. The governance angle is murkier — investors usually want a signal from large holders before they treat chair-and-CEO structure as anything more than a proxy-season skirmish.

But the near-term risk is that the stock gets dragged around by rates and growth expectations more than by proxy paperwork. A stronger-than-expected jobs print could push yields higher again, and a weaker one could stoke worries about a spending slowdown — neither is clean for a stock priced for steady, mid-cycle growth.

Next up is the U.S. Employment Situation report for December 2025, due Friday at 8:30 a.m. ET, followed by the December CPI report on Jan. 13 and the Federal Reserve’s Jan. 27-28 policy meeting for fresh guidance on rates.

Stock Market Today

  • Trump's Truth Social Withdraws Bitcoin and Bitcoin-Ethereum ETF Applications Amid Market Pressure
    May 20, 2026, 7:22 AM EDT. Trump Media & Technology Group has withdrawn its applications for Bitcoin and Bitcoin-Ethereum exchange-traded funds (ETFs), citing a strategic shift to pursue a different regulatory framework under the Investment Company Act of 1940 ('40 Act) instead of the Securities Act of 1933 ('33 Act). Yorkville America, the investment advisor, highlighted that the '40 Act allows more flexible investment strategies. This move comes amid intense fee competition in the U.S. spot Bitcoin ETF market, valued at $57.4 billion since January 2024, following Morgan Stanley's MSBT launch, which offers a low 0.14% expense ratio. The withdrawal underscores heightened competition and evolving regulatory approaches in the crypto ETF space.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Lockheed Martin stock jumps on Trump’s $1.5 trillion defense-budget call after payout-ban scare
Previous Story

Lockheed Martin stock jumps on Trump’s $1.5 trillion defense-budget call after payout-ban scare

Abivax stock slides 9% after Sofinnova flags $134m sale plan, with 2026 trial clock ticking
Next Story

Abivax stock slides 9% after Sofinnova flags $134m sale plan, with 2026 trial clock ticking

Go toTop